Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and Prostatitis

beta-lactams has been researched along with Prostatitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Almirante, B; Bosch-Nicolau, P; Burgos, J; Marquez-Algaba, E; Pigrau, C; Serra-Pladevall, J; Viñado, B1
Farrell, R; Kopacz, J; Mariano, N; Piracha, N; Prasad, N; Segal-Maurer, S; Shakil, J; Tarasuk, A; Urban, C; Wang, G1
Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N1
Boisseau, D; Ferry-Blanco, C; Forestier, E; Gros, S; Labe, A; Lecomte, C; Levast, M; Peynaud, D; Rogeaux, O1

Other Studies

4 other study(ies) available for beta-lactams and Prostatitis

ArticleYear
Risk Factors for Relapse in Acute Bacterial Prostatitis: the Impact of Antibiotic Regimens.
    Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; beta-Lactams; Chronic Disease; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Prostatitis; Pyelonephritis; Quinolones; Recurrence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination

2021
Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Urology, 2014, Volume: 83, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Image-Guided Biopsy; Infusions, Parenteral; Male; Middle Aged; Outpatients; Prevalence; Prospective Studies; Prostate; Prostatitis; Rectum; Ultrasonography, Interventional

2014
New Delhi metallo-beta-lactamase from traveler returning to Canada.
    Emerging infectious diseases, 2011, Volume: 17, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine

2011
[Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cystitis; Drug Evaluation; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prostatitis; Pyelonephritis; Recurrence; Retrospective Studies; Risk Factors

2012